In vitro effects of the CCR5 inhibitor maraviroc on human T cell function

By Arberas H.   Guardo A. C.   Bargalló M. E.   Maleno M. J.   Calvo M.   Blanco J. L.   García F.   Gatell J. M.   Plana M.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 3, 2013-03 ,pp. : 577-586

Oxford University Press

Access to resources Recommend Favorite

The chemokine receptor CCR5 genetic polymorphism and expression in rheumatoid arthritis patients

By Kohem C. L.   Brenol J. C. T.   Xavier R. M.   Bredemeier M.   Brenol C. V.   Dedavid T. L.   Silva e.   Mello A. de Castilhos   Cañedo A. D.   Neves A. G.   Chies J. A. B.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 5, 2007-01 ,pp. : 359-364

Informa Healthcare

Access to resources Recommend Favorite

Update on D-Ala-Peptide T-Amide (DAPTA): A Viral Entry Inhibitor that Blocks CCR5 Chemokine Receptors

By  

Current HIV Research, Vol. 1, Iss. 1, 2003-01 ,pp. : 51-67

Bentham Science Publishers

Access to resources Recommend Favorite

Beta-chemokine receptor CCR5 in human spermatozoa and its relationship with seminal parameters

By Barbonetti A.   Vassallo M.R.C.   Pelliccione F.   D'Angeli A.   Santucci R.   Muciaccia B.   Stefanini M.   Francavilla F.   Francavilla S.  

Human Reproduction, Vol. 24, Iss. 12, 2009-12 ,pp. : 2979-2987

Oxford University Press

Access to resources Recommend Favorite

The Δccr-5 Mutation in the CCR-5 Chemokine Receptor Gene Conferring Resistance to Human Immunodeficiency Virus Type 1: Frequency in Kuwait

By  

Medical Principles and Practice, Vol. 7, Iss. 4, 1998-11 ,pp. : 271-276

Karger

Access to resources Recommend Favorite